WBA vs. DNA
WBA (Walgreens Boots Alliance, Inc.) and DNA (Ginkgo Bioworks Holdings, Inc.) are both stocks. Both are in the Healthcare sector — WBA in Pharmaceutical Retailers, DNA in Biotechnology. At a 0.24 correlation, their price movements are largely independent.
Performance
WBA vs. DNA - Performance Comparison
Loading charts...
Returns By Period
WBA
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
DNA
- 1D
- 9.82%
- 1M
- 15.70%
- YTD
- 17.09%
- 6M
- 9.20%
- 1Y
- 5.88%
- 3Y*
- -47.70%
- 5Y*
- -52.38%
- 10Y*
- —
WBA vs. DNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
WBA Walgreens Boots Alliance, Inc. | 0.00% | 28.40% | -61.34% | -25.09% | -25.06% | 0.64% |
DNA Ginkgo Bioworks Holdings, Inc. | 17.09% | -15.38% | -85.47% | 0.00% | -79.66% | -21.68% |
Correlation
The correlation between WBA and DNA is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since Apr 19, 2021 | 0.24 |
Over the past year, the correlation between WBA and DNA has dropped to 0.01 - well below their long-term average of 0.24, suggesting their price drivers have been diverging.
Fundamentals
WBA:
$154.58B
DNA:
$121.84M
WBA:
$26.47B
DNA:
$99.27M
WBA:
-$2.92B
DNA:
-$218.90M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WBA vs. DNA — Risk / Return Rank
WBA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
DNA
WBA vs. DNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Walgreens Boots Alliance, Inc. (WBA) and Ginkgo Bioworks Holdings, Inc. (DNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| WBA | DNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.10 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 0.09 | — |
| Martin ratioReturn relative to average drawdown | — | 0.15 | — |
Loading charts...
Drawdowns
WBA vs. DNA - Drawdown Comparison
Loading charts...
Drawdown Indicators
| WBA | DNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -99.10% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -66.05% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -94.72% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -99.10% | — |
Current DrawdownCurrent decline from peak | — | -98.37% | — |
Average DrawdownAverage peak-to-trough decline | — | -79.98% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 39.81% | — |
Volatility
WBA vs. DNA - Volatility Comparison
Loading charts...
Volatility by Period
| WBA | DNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 21.26% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 71.35% | — |
Volatility (1Y)Calculated over the trailing 1-year period | — | 98.09% | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | — | 98.06% | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | — | 96.27% | — |
Dividends
WBA vs. DNA - Dividend Comparison
Neither WBA nor DNA has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DNA Ginkgo Bioworks Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
WBA Walgreens Boots Alliance, Inc. | 0.00% | 0.00% | 10.72% | 7.35% | 5.13% | 3.62% | 4.64% | 3.04% | 2.46% | 2.13% | 1.78% | 1.64% |
Financials
WBA vs. DNA - Financials Comparison
This section allows you to compare key financial metrics between Walgreens Boots Alliance, Inc. and Ginkgo Bioworks Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
WBA and DNA have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for WBA and DNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer